Skip to content
ppharmaranks
Menu

NEVIRAPINE vs VIRAMUNE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Rating

66/100
72/100

Pharmacy pays

~$4.55 /30
~$4.55 /30

Type

RX
RX

Active ingredient

NEVIRAPINE
NEVIRAPINE

Dosage forms

Suspension, Tablet, Tablet, extended release
Suspension, Tablet

Drug class

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

Boxed warning

Treats

Acquired Immunodeficiency Syndrome, Hiv Infections
Acquired Immunodeficiency Syndrome, Hiv Infections

Frequently asked questions

Which is better-rated, Nevirapine or Viramune?

By our independent rating, Viramune scores higher — 3.6 vs 3.3 out of 5 for Nevirapine. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Nevirapine or Viramune?

Pharmacies pay about the same to acquire either one — roughly $4.55 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Nevirapine and Viramune?

Both Nevirapine and Viramune share the active ingredient Nevirapine.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.